The Use of PDX1 DNA Methylation to Distinguish Two Subtypes of Pancreatic Neuroendocrine Neoplasms with Different Prognoses

The Use of PDX1 DNA Methylation to Distinguish Two Subtypes of Pancreatic Neuroendocrine Neoplasms with Different Prognoses

Pancreatic neuroendocrine neoplasms (pNENs) account for approximately 5% of all pancreatic tumors; thus, they constitute the second most common tumor type in the pancreas [...]

Bibliographic Details
Main Authors: Hendrik Ungefroren, Björn Konukiewitz, Ulrich F. Wellner, Jörg Schrader, Tobias Keck
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Cancers
Subjects:
n/a
Online Access:https://www.mdpi.com/2072-6694/15/1/160

Similar Items

Similar Items